FDA's approval of new cannabis-based drug will pave the way for similar meds, says CEO
June 26, 2018 at 17:14 PM EDT
The FDA's approval of a new epilepsy drug derived from the cannabis plant will pave the way for other medications, says GW Pharma CEO.
